Featured Pharma Online Editorial
-
At Base Camp: Lilly's Manufacturing Capacity Journey
2/13/2026
In 2025 alone, Lilly announced plans to build new facilities in Texas, Alabama, Virginia and Pennsylvania in addition to facility expansions in Indiana, Wisconsin and Puerto Rico.
-
The U.S. Has A New Vice To Squeeze Foreign Imports: Pharma Quality
2/13/2026
The Trump administration has effectively merged national security, trade policy, and drug quality. Now, foreign manufacturers lacking deals face paying a "quality tax."
-
Novo's Path To The First GLP-1 Weight Loss Pill
1/23/2026
The race to the finish line for the first oral GLP-1 treatment for weight loss was won on Dec. 22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.
-
A Deeper Look At Pharma's Structural Supply Chain Vulnerability
12/31/2025
Fixing limited capacity in pharmaceutical CMC development starts with understanding a complex web of root causes.
-
It's Copy/Paste In Fleet Management Manufacturing
12/11/2025
Copy and paste may be frowned upon in most work tasks, but not in the case of “fleet management.” In the past few years, Roche and Novo Nordisk collaborated to introduce this concept of applying the copy/paste action to standardized, decentralized facilities.
-
Four Reasons You Should Choose Lyophilization for Your Next Project
12/10/2025
Lyophilization ensures product stability, extends shelf life, supports sensitive formulations, and simplifies storage and transport, making it a critical choice for modern drug development projects.
-
Is Charisma An API?
11/19/2025
After nearly 20 years in the pharmaceutical industry, Samir Shah, director of regulatory CMC for medical products and combination products at AstraZeneca, knows how beneficial charisma can be for the pharmaceutical professional. That’s why he presented the topic at the 2025 RAPS Convergence.
-
Innovation, Growth (and Happiness) Projected for Pharma
11/10/2025
Not only is investment increasing in pharma, but innovation is propelling growth in multiple drug segments, and the people supporting this growth and innovation remain happy.
-
Global Implications Of Zero Tariffs On Indian Pharma Exports To China
11/5/2025
Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.
-
Are You Still Evaluating CMOs When You Really Need A CDMO?
10/29/2025
Outsourcing adds capacity and specialized knowledge to your supply chain. But contractors come in several types. Here's how to pick the right one.